首页> 外文期刊>Infectious diseases in obstetrics and gynecology >Effect of Intravaginal Clindamycin Cream on Pregnancy Outcome and on Abnormal Vaginal Microbial Flora of Pregnant Women
【24h】

Effect of Intravaginal Clindamycin Cream on Pregnancy Outcome and on Abnormal Vaginal Microbial Flora of Pregnant Women

机译:阴道克林霉素乳膏对孕妇妊娠结局和阴道微生物菌群异常的影响

获取原文
           

摘要

Objectives:To determine whether intravaginal clindamycin cream reduces the incidence of abnormalpregnancy outcome in women with abnormal vaginal microbial flora graded as intermediate orBV and to investigate the effect of the antibiotic on vaginal microbial flora.Methods:A prospective cohort study of pregnant women in an antenatal clinic of a districtgeneral hospital. The subjects were 268 women who had abnormal vaginal microbial flora at firstclinic visit by examination of a Gram-stained vaginal smear and 34 women with a normal vaginalflora. Two hundred and thirty-seven women were evaluable. Women with abnormal Gram-stainedsmears (graded as II or III) on clinic recall were randomised to receive treatment (intravaginalclindamycin cream) or placebo and followed to assess outcome of pregnancy, vaginal flora, anddetection ofMycoplasma hominisandUreaplasma urealyticumafter treatment.Results:Abnormal outcomes of pregnancy were not significantly different in treated and placebogroups by Chi square (P= 0.2). However, women with grade III flora responded better to clindamycinthan women with grade II flora by numbers of abnormal outcomes (P= 0.03) and return tonormal vaginal flora (P= 0.01) (logistic regression analysis model). This may be due to differencesin vaginal bacterial species in these grades. Women whose abnormal vaginal flora had spontaneouslyreturned to normal on follow-up and were therefore not treated (revertants) had as manyabnormal outcomes as placebos suggesting that damage by abnormal bacterial species occurredearly in pregnancy.Conclusions:Gram-stain screening distinguishing grade II from grade III flora may be helpfulin prescribing treatment other than clindamycin for women with grade II flora. Earlier diagnosisand treatment may be more effective in preventing an abnormal outcome, possibly as soon aspregnancy is diagnosed or even offered as a pre-conception screen. Infect. Dis. Obstet. Gynecol.8:158–165, 2000.
机译:目的:确定阴道内克林霉素乳膏能否降低分级为中间或BV的阴道微生物菌群异常的女性的异常妊娠结局的发生,并研究抗生素对阴道微生物菌群的影响。方法:前瞻性队列研究孕妇的产前研究地区综合医院的诊所。受试者为268位在首次诊所就诊时通过革兰氏染色阴道涂片检查具有异常阴道微生物菌群的女性,以及34位阴道菌群正常的女性。有237名妇女是可评估的。临床召回时革兰氏染色涂片异常(等级为II或III)的妇女被随机接受治疗(阴道内克林霉素乳膏)或安慰剂,然后评估治疗后的妊娠结局,阴道菌群和人型支原体和溶血性脲原体的检测结果:异常妊娠结局经卡方检验,治疗组和安慰剂组无显着差异(P = 0.2)。然而,具有III级菌群的女性比具有II级菌群的女性对克林霉素的反应更好,其异常结果数(P = 0.03)和恢复正常的阴道菌群(P = 0.01)(逻辑回归分析模型)。这可能是由于这些级别的阴道细菌种类不同所致。阴道菌群异常自发地恢复正常并因此未接受治疗的妇女(复归型)的异常结局与安慰剂一样多,这表明异常细菌种类的损害在妊娠早期就已发生。结论:革兰氏染色筛查可将II级与III级区分开除克林霉素外,对于患有II级菌群的女性,菌群可能有助于开处方治疗。早期诊断和治疗可能更有效地预防异常结局,可能是一旦诊断出妊娠甚至将其作为孕前筛查手段。感染。 Dis。 Obstet。 Gynecol.8:158–165,2000年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号